Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA
A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.
Laboratory tests using preparations of Ebola virus and other hemorrhagic fever viruses showed that the system has the sensitivity and specificity needed to provide a viable clinical assay. The team reported their results in a paper published September 25 in Nature Scientific Reports.
An outbreak of Ebola virus in West Africa has killed more than 11,000 people since 2014, with new cases occurring recently in Guinea and Sierra Leone. The current gold standard for Ebola virus detection relies on a method called polymerase chain reaction (PCR) to amplify the virus’s genetic material for detection. Because PCR works on DNA molecules and Ebola is an RNA virus, the reverse transcriptase enzyme is used to make DNA copies of the viral RNA prior to PCR amplification and detection.
“Compared to our system, PCR detection is more complex and requires a laboratory setting,” said senior author Holger Schmidt, the Kapany Professor of Optoelectronics at UC Santa Cruz. “We’re detecting the nucleic acids directly, and we achieve a comparable limit of detection to PCR and excellent specificity.”
In laboratory tests, the system provided sensitive detection of Ebola virus while giving no positive counts in tests with two related viruses, Sudan virus and Marburg virus. Testing with different concentrations of Ebola virus demonstrated accurate quantification of the virus over six orders of magnitude. Adding a “preconcentration” step during sample processing on the microfluidic chip extended the limit of detection well beyond that achieved by other chip-based approaches, covering a range comparable to PCR analysis.
“The measurements were taken at clinical concentrations covering the entire range of what would be seen in an infected person,” Schmidt said.
Schmidt’s lab at UC Santa Cruz worked with researchers at Brigham Young University and UC Berkeley to develop the system. Virologists at Texas Biomedical Research Institute in San Antonio prepared the viral samples for testing.
The system combines two small chips, a microfluidic chip for sample preparation and an optofluidic chip for optical detection. For over a decade, Schmidt and his collaborators have been developing optofluidic chip technology for optical analysis of single molecules as they pass through a tiny fluid-filled channel on the chip. The microfluidic chip for sample processing can be integrated as a second layer next to or on top of the optofluidic chip.
Schmidt’s lab designed and built the microfluidic chip in collaboration with coauthor Richard Mathies at UC Berkeley who pioneered this technology. It is made of a silicon-based polymer, polydimethylsiloxane (PDMS), and has microvalves and fluidic channels to transport the sample between nodes for various sample preparation steps. The targeted molecules–in this case, Ebola virus RNA–are isolated by binding to a matching sequence of synthetic DNA (called an oligonucleotide) attached to magnetic microbeads. The microbeads are collected with a magnet, nontarget biomolecules are washed off, and the bound targets are then released by heating, labeled with fluorescent markers, and transferred to the optofluidic chip for optical detection.
Schmidt noted that the team has not yet been able to test the system starting with raw blood samples. That will require additional sample preparation steps, and it will also have to be done in a biosafety level 4 facility.
The Latest on: Ebola detection
via Google News
The Latest on: Ebola detection
- Doctor who survived Ebola: US needs more coronavirus testing to prevent 'constant interruptions'on May 12, 2020 at 3:15 pm
"We don't have what we need in place to be able to do what needs to be done well, the good bread-and-butter public health: testing, contact tracing, isolating," said Dr. Craig Spencer of New ...
- Tracking changes: On Mayor de Blasio’s poorly explained plans to move coronavirus testing and tracing out of the Health Departmenton May 12, 2020 at 1:41 am
Mayor de Blasio raised hackles in public health circles last week when he announced plans to run the city’s massive new COVID-19 testing-and-tracing program through the city’s public hospitals instead ...
- Co-Diagnostics Is a Smart Way to Play Coronavirus Testingon May 11, 2020 at 5:25 am
Diagnostics says its coronavirus tests are 100% accurate in tests in three countries, making CODX stock a smart play.
- How Ebola Helped Africa Prepare for Coronaviruson May 8, 2020 at 8:00 pm
HIV/Aids, Lassa fever, and tuberculosis are just some of the communicable diseases that African health experts are used to dealing with, and many realized the danger of the coronavirus as soon as they ...
- How Lessons From Ebola Can Help Fight COVID-19on May 8, 2020 at 3:12 am
An infectious disease specialist in Atlanta is drawing on his experiences treating Ebola patients while caring for those with COVID-19.
- Learning from the Ebola Outbreak to Fight COVID-19 in IOM Sierra Leoneon May 8, 2020 at 3:00 am
English News and Press Release on Sierra Leone about Disaster Management, Water Sanitation Hygiene and Epidemic; published on 08 May 2020 by IOM ...
- The double burden of coronavirus and Ebola in eastern DRCon May 8, 2020 at 2:24 am
COVID-19 comes to complicate an already difficult situation, as the region struggles from both armed conflict and an Ebola outbreak that has lasted nearly two years and infected thousands.
- Outlook on the Worldwide Virus Testing Kits Industry to 2025 - Featuring Abbott, Autobio Diagnostics & Beckman Coulter Among Otherson May 7, 2020 at 2:26 am
The "Global Virus Testing Kits Market By Test Type (DFA, Polymerase Chain Reaction (PCR)-Based Tests, Agglutination Assays, Solid-Phase Assays,.
- 4 things to know about coronavirus testing with Dr. Rajiv Shah of the Rockefeller Foundationon May 6, 2020 at 11:38 am
"When you don't have data, you can't drive a data driven pandemic response and you end up either reopening everything or shutting everything down," Shah told "Face the Nation" moderator Margaret ...
- Rep. Sheila Jackson Lee: Universal testing for coronavirus is a national security issue [Opinion]on May 6, 2020 at 1:15 am
I called another press conference to urge that testing be given the highest priority in battling the spread of the new coronavirus and the sickness it causes called COVID-19. And I continue to ...
via Bing News